BTI
DMAC icon

Blue Trust Inc’s DiaMedica Therapeutics DMAC Stock Holding History

Blue Trust Inc’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Hold
69,122
– – 0.01% 495
2026
Q1 		$468K Hold
69,122
– – 0.01% 500
2025
Q4 		$550K Hold
69,122
– – 0.01% 453
2025
Q3 		$475K Hold
69,122
– – 0.01% 510
2025
Q2 		$270K Hold
69,122
– – ﹤0.01% 660
2025
Q1 		$262K Hold
69,122
– – ﹤0.01% 619
2024
Q4 		$375K Buy
69,122
+24,875
+56% +$117K ﹤0.01% 455
2024
Q3 		$131K Buy
+44,247
New +$163K ﹤0.01% 1078

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Blue Trust Inc's DMAC Position: Q2 2026 in Review

Blue Trust Inc held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 69,122 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #495.

Blue Trust Inc first reported a position in DMAC in Q3 2024 and has held it in 8 quarters since. The position peaked at $550K in Q4 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Blue Trust Inc held 69,122 shares of DiaMedica Therapeutics worth $487K as of Q2 2026.
  • Blue Trust Inc left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #495 holding.
  • Blue Trust Inc first reported a position in DiaMedica Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Blue Trust Inc's DiaMedica Therapeutics position peaked at $550K in Q4 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.